-
公开(公告)号：US12065488B2
公开(公告)日：2024-08-20
申请号：US17516082
申请日：2021-11-01
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
公开(公告)号：US11180549B2
公开(公告)日：2021-11-23
申请号：US16717594
申请日：2019-12-17
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
公开(公告)号：US20160222104A1
公开(公告)日：2016-08-04
申请号：US15132851
申请日：2016-04-19
Applicant: Janssen Biotech, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: C07K16/24
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.
Abstract translation: 包含具有液体制剂的抗IL-6抗体的笔式注射器装置在诊断和/或治疗组合物，方法和装置中具有应用。
-
4.发明申请Methods of Treating TNF-alpha-Mediated Diseases Using Chimeric TNF-alpha Antibodies 审中-公开使用嵌合TNF-α抗体治疗TNF-α介导的疾病的方法公开(公告)号：US20140212413A1
公开(公告)日：2014-07-31
申请号：US14158699
申请日：2014-01-17
Applicant: New York University , Janssen Biotech, Inc.
Inventor： Junming Le , Jan T. Vilcek , Peter E. Daddona , John Ghrayeb , David M. Knight , Scott A. Siegel
IPC: A61K39/395 , A61K31/519 , A61K45/06 , C07K16/24
CPC classification number: A61K45/06 , A61K31/519 , A61K2039/505 , C07K16/241 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/76 , A61K2300/00 , A61K39/3955
Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract translation: 对人肿瘤坏死因子-α（TNFα）特异性的抗TNF抗体，其片段和区域，可用于许多TNFα介导的病理学和病症的体内诊断和治疗，以及编码鼠和嵌合体的多核苷酸 提供了免疫测定和免疫治疗方法中的抗体，抗体的制备方法，抗TNF抗体的使用方法或其片段，区域或衍生物。
-
公开(公告)号：US20140099311A1
公开(公告)日：2014-04-10
申请号：US14096596
申请日：2013-12-04
Applicant: Applied Molecular Evolution, Inc. , Janssen Biotech, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-Yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan H. Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: C07K16/24
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Abstract translation: 抗IL-6抗体，包括编码至少一种抗IL-6抗体，载体，宿主细胞，转基因动物或植物的分离的核酸及其制备和使用的方法具有在诊断和/或治疗组合物中的应用 ，方法和设备。
-
Patent Agency Ranking
公开(公告)号：US20130183298A1
公开(公告)日：2013-07-18
申请号：US13786445
申请日：2013-03-05
Applicant: Janssen Biotech, Inc. , New York University
Inventor： Junming Le , Jan T. Vilcek , Peter E. Daddona , John Ghrayeb , David M. Knight , Scott A. Siegel
IPC: A61K39/395 , A61K31/519 , A61K45/06 , A61K45/00
CPC classification number: A61K39/3955 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/485 , A61K31/519 , A61K31/573 , A61K38/00 , A61K45/00 , A61K45/06 , A61K2039/505 , C07K14/525 , C07K16/241 , C07K16/30 , C07K2317/24 , C07K2317/34 , C07K2317/76 , C07K2317/92 , C07K2319/00 , A61K2300/00
Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract translation: 抗TNF抗体，其对人肿瘤坏死因子-α（TNFalpha）特异性的片段和区域，并且可用于许多TNFα介导的病理学和病症的体内诊断和治疗，以及编码鼠和嵌合体的多核苷酸 提供了免疫测定和免疫治疗方法中的抗体，抗体的制备方法，抗TNF抗体的使用方法或其片段，区域或衍生物。
-
公开(公告)号：US11078267B2
公开(公告)日：2021-08-03
申请号：US16677120
申请日：2019-11-07
Applicant: Janssen Biotech, Inc.
Inventor： Jill Giles-Komar , David M. Knight , David Peritt , Bernard Scallon , David Shealy
IPC: A61K39/395 , C07K16/24 , A61K45/06 , A61K39/00
Abstract: Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as systemic lupus erythematosus.
-
公开(公告)号：US20190248884A1
公开(公告)日：2019-08-15
申请号：US16284316
申请日：2019-02-25
Applicant: Janssen Biotech, Inc.
Inventor： Jill Giles-Komar , David M. Knight , David Peritt , Bernard Scallon , David Shealy
IPC: C07K16/24 , A61K39/395 , A61K45/06
Abstract: Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as systemic lupus erythematosus.
-
公开(公告)号：US10259867B2
公开(公告)日：2019-04-16
申请号：US15583487
申请日：2017-05-01
Applicant: Janssen Biotech, Inc.
Inventor： Jill Giles-Komar , David M. Knight , David Peritt , Bernard Scallon , David Shealy
IPC: A61K39/395 , C07K16/24 , A61K45/06 , A61K39/00
Abstract: Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as psoriasis.
-
公开(公告)号：US20170253651A1
公开(公告)日：2017-09-07
申请号：US15461886
申请日：2017-03-17
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xioa-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: A61K39/395
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
-
-
-
-
-
-
-
-
Search Results
24
records
(took 0.028 seconds)
